Chronic kidney disease is a worldwide public health problem and a chronic disease that deteriorates the quality of life (QOL). Diabetes is recognized as co-morbidity in patients of end stage renal disease (ESRD). This study evaluated QOL in diabetic and non-diabetic patients on maintenance dialysis therapy. A cross-sectional study was conducted on ESRD with or without diabetes on hemodialysis therapy for at least three months at Kidney Center, Sheikh Zayed Medical Complex, Lahore Pakistan. QOL was assessed using WHOQOL-BREF questionnaire by World Health Organization. One hundred and thirty seven (n=137) hemodialysis patients were observed. 59 (41.8%) were with diabetes mellitus (DM) and 78 (55%) were without DM. 81 (54%) were on hemodialysis for more than 2 years. There was no statistically significant (p≥0.066) difference in QOL scores of hemodialysis patients with or without diabetes; however, a significant (p≤0.025) difference was observed in responses of ‘meaningfulness’ and “ability to concentrate” by patients of both groups. The scores were divided in two categories of ‘≤50’ and ‘>50’; a significant (p≤0.047) difference between two groups was observed in physical domain only. The current study on diabetic and non-diabetic hemodialysis patients showed no statistical difference in their QOL except for “meaningfulness of life” and “ability to concentrate”.
Key words: End stage renal disease (ESRD), diabetes mellitus (DM), quality of life (QOL), hemodialysis.
Copyright © 2020 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0